week 2 Flashcards

1
Q

What is the current drug discovery process?

A

arduous and costly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What does majority of drug candidate entering clinical trial fail to make?

A

to the marketplace

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What does microengineering and microfluidics provide?

A
  1. microeenginering provide precise control over cellular microenvironment
  2. Microfluidics provide ability to perfuse the constructs on a chip and to connect individual sections with each other
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What does the organ-on-a-chip platform be utilized for?

A

Developing disease model as well as conducting for drug testing studies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Why is there such a low success rate ?

A

Inability to predict the toxicity and efficacy of drugs before expensive human clinical trials

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What does microfabrication and microfluidic technologies create?

A

small structures for a variety of applications in biotechnology

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

In drug discovery, what can micro-scale platform allow?

A

precise delivery of fluids with reduced reagent volumes and can be utilised for high-throughput screening

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What can Microengineering technologised be used for?

A

Fabricating tissue-like structures that mimic the natural complexity of tissues

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What may these microscale tissue platform be useful in?

A

Recreating the intricacies of the in-vivo environment with microscale precision and provide mechanical chemical or electrical cues representative of living environment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What can microscale perfusion bioreactors be generated for

A

Manipulation of biological materials such as proteins, cells or tissues

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What can be used to stimulate signals from brain slices?

A

the fabrication of

metal electrodes on ultra thin stretchable substrates

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what is being developed to

monitor tissue viability and functionality in real-time

A

on-chip sensors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What can ‘organs-on-a-chip’ provide?

A

opportunities to probe the

cellular behavior against a plethora of stimuli

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What can organ-on-chip create?

A
  1. disease models

2. perfused to create dynamic culture environments

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What did Aubin et al study?

A

three-dimensional functionality of cardiac tissue using microscale hydrogels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What did Aubin et el do?

A
  1. cardiomyctes were encapsulated inside hydrogels with different micropatterns and align and form fiber-like structures
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What did the results of Aubin et al study indicate?

A

Microscale scaffolds could be engineered to mimic the size and shape of individual cardiac fibers in vivo

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What did Giridharan et al culture?

A

embryonic cardiac cells inside a microscale cylindrical bioreactor and exposed them to pulsatile flow and varying strains to mimic cardiac cycle in left heart ventricle

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What can devices like merging, electrical, chemical and mechanical impulses with a tissue culture reactor be utilized for?

A

Studies of human stem-cell derived cardiac cells

  1. predict toxicity of drugs and environmental agents on the human heart
  2. enable development of more efficient treatment for common diseases such as arrythmia
  3. lead to personalized medicine - allow drug testing on patients own cells to maximise success of treatment
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Define medical translation

A

The practice of translating various documents

  1. training materials
  2. medical bulletins
  3. drug data sheets

for health care

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What is important in the medical field for translation?

A

Avoid all errors in comprehension, change or suppression of information

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What does not often translate effectively to human conditions?

A

drug efficacy in experimental disease model

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

what can overreliance on animal studies lead to?

A

inappropriate conclusion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

How do we translate?

A

pop into cell (GPCR)

talk to evoke a response in cell

messengers may be different to therapeutic target

important to have allosteric mediators to help

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

What should we consider when doing translation?

A
  1. native tissue
  2. intact neurocircuitry
  3. species-specific paths/receptors
  4. therapeutic relevance
  5. access to disease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Why is host cell coupling mis-leading?

A

popping loads of receptors into the cell so that an agonist starts to look like an antagonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

What happens as you pop GPCR?

A
  1. couples
  2. secondary messengers
  3. amplify a response when you start measuring
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

What is important for drug discovery and for basic biology?

A

Accurate measurements of affinity and efficacy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

what underpins analyses of ligand/receptor interaction in both SAR and mutagenesis analysis

A

The receptor structure and function

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

What remains largely unknown?

A

The molecular basis for morphological, physiological, biochemical and behavioural variation in laboratory mice

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

What enabled our ability to relate sequence to function?

A

decoding the complete genome of one strain C57BL/6J (the mouse reference genome)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

What accelerated the discovery of mouse sequence diversity?

A

Creating a complete set of null alleles for all genes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Genome sequence of 17 inbred strains of laboratory mice

A

Identify almost ten times more variants than previously known

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

What was used to explore phylogenetic history of laboratory mouse

A

genome sequence of inbred strains

  1. examine functional consequence of allele-specific variation on transcript abundance
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

What does 12% of transcripts show?

A

Significant tissue-specific expression bias

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

What was the total count in 17 strains?

A

56.6M unique sites

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

What are other types of sequence polymorphism that have previously been difficult to assess on a genome- wide scale?

A

Indels at 8.8M unqiue sites and 0.28M structural variants

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

How often are mouse models proven to be relevant to human disease?

A
  1. Humans have a different receptor identification
  2. It is not a simple cell - intact neurocircuitry
  3. Mice and humans have evolved in and became adapted to different environment
  4. Mice often respond to experimental intervention in ways that differ strikingly from humans
  5. mouse strains have phenotypes that differ from human counterparts
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

A phase III trial

A

90% of total drug development cost (>1 billon)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

What is the GI hormone motilin?

A

A substance released from the duodenum to increase gastric emptying

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

In human, where is motilin released from?

A

Fasting and after eating

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

What is motilin?

A

highly conserved across species

22 amino acid peptide hormone expressed throughout GI of humans and other species

43
Q

What does motilin affect?

A

Gastric motility by stimulating interdigestive antrum and dudodenal contractions

44
Q

What does motilin receptor activation affect?

A

brain function in rats and mice

45
Q

What was increased by low concentration of motilin?

A

electrically-evoked, cholinergically mediated contractions of humans and rabbit isolated stomach

46
Q

What does the major therapeutic activity of motilin receptor agonist relies on?

A

Faciliatation of cholinergic activity

47
Q

Where was the motilin gene found to be absent in?

A

Rodents where the receptors are pseudogenes

48
Q

What shares common ancestry with motilin?

A

Ghrelin

49
Q

What is the specific absence of functional motilin associated with?

A

Specialised digestive physiology, including:

  1. loss of ability to vomit
50
Q

What is motilin conserved to regulate?

A

caecotrophy

specialised digestive strategy

51
Q

What is motilin receptor agonist being under development as?

A

gastroprokinetic drugs

52
Q

What are gastroprokinetic drugs?

A

medications that help control acid flux

53
Q

What do human and rodent kappa opioid receptors share?

A

~94% AA sequence homolgy

54
Q

what was the opioid receptor gene, in humans rats and mouse ORPK aligned using?

A

ClustalX

55
Q

What was evaluated for potential impact on G-protein coupling?

A

Amino acid in the third intracellular loop

C terminus of OPRK

in the 3rd intracellular loop and C terminal region

56
Q

What is found in the 3rd intracellular region?

A

Ala308Val (neutral substitution in rat)

57
Q

What is found in C terminal region in rat and mouse?

A
  1. Leu348IIE

2. Ser358Asn

58
Q

what was ICI204448 and asimadoline found to be?

A

approximately equi-effective and equi-potent inhibitors of response to EFS

59
Q

What had a slower onset of action?

A

Asimadoline

60
Q

What acts as a kappa receptor agonist?

A

ICI204448 and asimadoline

61
Q

What reduced contractions of the distal colon ?

A

ICI204448 and asimadoline

62
Q

What did low concentration of asimadoline reduce?

A

the activity of ICI204448

63
Q

What is an issue of translation with host cells and tissues?

A

one compound may have 100% efficacy and other compound 50% efficacy

64
Q

Define pharmacokinetics

A

How the body affects a specific chemical after administration

65
Q

Define oral bioavailability

A

The fraction of an oral administered drug that reaches systemic circulation

66
Q

What happens after intravenous administration?

A

A drug is directly and fully available in the bloodstream

can be distributed via systemic circulation to a point where a pharmacological effect takes place

67
Q

What happens if a drug is administered orally?

A

has to cross further barriers to reach systemic circulation

can significantly reduce the final extent of a drug in bloodstream

68
Q

what can high oral bioavailability reduce?

A

The amount of administered drug necessary to achieve a desired pharmacological effect

reduce the risk of side-effects and toxicity

69
Q

What can a low oral bioavailibility result in?

A
  1. low efficacy
  2. higher inter-individual variability
  3. give unpredictable response to a drug
70
Q

What happens when a drug survives gut?

A

Go to small intestine

71
Q

Features of small intestine

A

Area of high degree of absroption

  1. foldings - villi - protrusions like microvilli
  2. lined with capillaries - absorbed into the portal vein which drains the intestine to liver
72
Q

Define first pass metabolism

A

Concentration of the drug is greatly reduced before it reaches the systemic circulation

73
Q

What does the liver do?

A

Detoxifies and metabolises substances and drugs by oxidation

74
Q

What are the features of blood brain barrier?

A
  1. mostly endothelial - plenty of gaps b/w epithelia
  2. tight junctions between epithelial

protect from fluctuations

  1. carrier proteins within epithelial to kick stuff out
75
Q

Define pharmacodynamics

A

How a specific chemical affects function of the body after administration

76
Q

Where does efficacy of molecules exist in?

A

In-vivo

exert activity at the receptor in native environment

77
Q

What has corticotropin-releasing factor type 1 (CRF1) been implicated in?

A

increased emotionality accompanying exposure to environmental stressors

78
Q

What is function of agonist CRF?

A
  1. produce anxiogenic-like behaviour

2. potentiate the effects of stressor exposure

79
Q

What does limbic and brain stem region promote?

A

Arousal and fear-like behaviours

enriched with CRF1 receptors

80
Q

What does CRF1 receptor knock down produce?

A

Calming , anti-stress effects

81
Q

what is a stressor that activates the hypothalamo-pituitary-adrenal axis and produces an anxiogenic-like behavioral response ?

A

Swim Stressor forced swimming at ambient water temperature

82
Q

What was Swim stressor forced swimming at ambient water temperatures?

A
  1. Rats exposed to water (21-23C) in a pool for 90S

2. The animal was placed in the pool and allowed to swim or float with no means of climbing out

83
Q

What is a validated testing model of anxiety?

A

The elevated plus-maze

four-arms constructed

2 of arms were enclosed with walls and two arms had no walls

subjects placed individually onto centre of maze facing of the closed arms and allowed free access to all four arms for 5 mins

time spent on each arm was recorded

84
Q

What is selectivity of action?

A

ability of a drug to act against a range of other receptors, channels and enzymes

85
Q

What may selectivity of action be associated with?

A

Unwanted side effects

86
Q

What does selective toxicity refer to?

A

The ability of drug to target sites that are relative specific to microogranism responsible for infection

87
Q

What do patients do?

A
  1. Take bigger doses
  2. Take multiple drugs
  3. Never read labels
  4. Never take advice
88
Q

Define Therapeutic window

A

Difference between effective dose and toxic doses

89
Q

What is TD 50?

A

Dose toxic for 50% of population

90
Q

What is ED 50?

A

minimum effective dose for 50% of population

91
Q

what is TI?

A

TD50/ED5-

92
Q

What is ADR?

A
  1. Adverse drug reactions

2. receptor variations that could cause a serious side effects

93
Q

Drug-Drug interactions

A

Within medicine you do not know hypothesis will work until it is tested and followed for a long time

highly unpredictable

94
Q

What is the 5th most common cause of hospital death?

A

ADR

95
Q

What can pharmacovigilance reduce?

A

death and suffering caused by adverse reactions

96
Q

what happened in 2000 on ADR?

A

has been on the market for 7 years and started to be associated with cardiac arrythmia

97
Q

What does ADR hit?

A

delayed rectifier potassium cycle- delaying the cardiac cycle

98
Q

What is hERG?

A

φ φ hERG is a gene that codes for a protein known as Kv11.1, the alpha subunit of a potassium ion channel.

99
Q

What is hERG best known for?

A

This ion channel is best known for its contribution to the electrical activity of the heart: the hERG channel mediates the repolarizing IKr current in the cardiac action potential, which helps coordinate the heart’s beating.

100
Q

What can hERG lead to?

A

a potentially fatal disorder called long QT syndrome.

101
Q

What may not be translated to humans?

A
  • Pain
  • Anxiety
  • Irritable bowel syndrome
102
Q

How do you convince boss about efficacy, kinetics, selectivity, properties- but then unsure if it cures the disease as there is no animal model available that you trust ?

A

φ Can measure surrogate effect and mechanistic pathways
φ Cannot do anything at all and take a novel candidate to human and test it on- if the clinical need is high enough go straight to human

103
Q

Other factors to consider before selection

A
  1. Save enough to invest further
  2. Early elimination of obviously toxic compounds
  3. have conducted at least some safety evaluations (‘toxicology’)